• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase.骨髓衰竭和肺纤维化综合征预示着端粒酶的种系缺陷。
Blood. 2011 May 26;117(21):5607-11. doi: 10.1182/blood-2010-11-322149. Epub 2011 Mar 24.
2
Telomerase and idiopathic pulmonary fibrosis.端粒酶与特发性肺纤维化。
Mutat Res. 2012 Feb 1;730(1-2):52-8. doi: 10.1016/j.mrfmmm.2011.10.013. Epub 2011 Nov 4.
3
Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.结构分析揭示端粒酶突变在骨髓衰竭综合征中的有害影响。
J Biol Chem. 2017 Mar 17;292(11):4593-4601. doi: 10.1074/jbc.M116.771204. Epub 2017 Feb 1.
4
Telomerase mutations in families with idiopathic pulmonary fibrosis.特发性肺纤维化家族中的端粒酶突变
N Engl J Med. 2007 Mar 29;356(13):1317-26. doi: 10.1056/NEJMoa066157.
5
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.端粒长度、肺纤维化和端粒酶(TERT)突变。
PLoS One. 2010 May 19;5(5):e10680. doi: 10.1371/journal.pone.0010680.
6
A spectrum of severe familial liver disorders associate with telomerase mutations.一系列严重的家族性肝脏疾病与端粒酶突变有关。
PLoS One. 2009 Nov 20;4(11):e7926. doi: 10.1371/journal.pone.0007926.
7
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.端粒酶逆转录酶单倍剂量不足导致常染色体显性遗传性先天性角化不良的遗传早现。
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15960-4. doi: 10.1073/pnas.0508124102. Epub 2005 Oct 24.
8
Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.先天性角化不良中造血功能衰竭的评估与管理
Hematol Oncol Clin North Am. 2018 Aug;32(4):669-685. doi: 10.1016/j.hoc.2018.04.003. Epub 2018 May 28.
9
Telomere length in inherited bone marrow failure syndromes.遗传性骨髓衰竭综合征中的端粒长度
Haematologica. 2015 Jan;100(1):49-54. doi: 10.3324/haematol.2014.114389. Epub 2014 Oct 10.
10
Dyskeratosis congenita and telomerase.先天性角化不良与端粒酶
Curr Opin Pediatr. 2004 Feb;16(1):23-8. doi: 10.1097/00008480-200402000-00006.

引用本文的文献

1
Viewpoint: Pre- and post-lung transplant considerations for patients with ultra-short telomere length.观点:端粒长度极短患者肺移植前后的注意事项
Eur Respir J. 2025 Mar 6;65(3). doi: 10.1183/13993003.01545-2024. Print 2025 Mar.
2
Progressive lung fibrosis: reprogramming a genetically vulnerable bronchoalveolar epithelium.进行性肺纤维化:对具有遗传易感性的支气管肺泡上皮进行重编程。
J Clin Invest. 2025 Jan 2;135(1):e183836. doi: 10.1172/JCI183836.
3
Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype.端粒延长种系变异易患综合征型甲状腺乳头状癌亚型。
Am J Hum Genet. 2024 Jun 6;111(6):1114-1124. doi: 10.1016/j.ajhg.2024.04.006. Epub 2024 Apr 29.
4
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.肺纤维化的遗传学和基因组学:描绘分子图谱,塑造精准医学。
Am J Respir Crit Care Med. 2024 Aug 15;210(4):401-423. doi: 10.1164/rccm.202401-0238SO.
5
Telomeres: Dysfunction, Maintenance, Aging and Cancer.端粒:功能障碍、维护、衰老和癌症。
Aging Dis. 2023 Nov 29;15(6):2595-2631. doi: 10.14336/AD.2023.1128.
6
Diagnosis and Management of Pulmonary Manifestations of Telomere Biology Disorders.诊断和管理端粒生物学障碍的肺部表现。
Curr Hematol Malig Rep. 2024 Dec;19(6):285-292. doi: 10.1007/s11899-023-00720-9. Epub 2023 Dec 30.
7
Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology Disorders.端粒生物学障碍中的适应性和不适应性克隆性造血
Curr Hematol Malig Rep. 2024 Feb;19(1):35-44. doi: 10.1007/s11899-023-00719-2. Epub 2023 Dec 14.
8
p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes.骨髓衰竭综合征分子通路中的p53
Int J Mol Sci. 2023 Oct 6;24(19):14940. doi: 10.3390/ijms241914940.
9
Genetic Counseling and Family Screening Recommendations in Patients with Telomere Biology Disorders.端粒生物学障碍患者的遗传咨询和家族筛查建议
Curr Hematol Malig Rep. 2023 Dec;18(6):273-283. doi: 10.1007/s11899-023-00713-8. Epub 2023 Oct 3.
10
Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma.端粒长度和 hTERT 基因变异作为多发性骨髓瘤潜在的预后标志物。
Sci Rep. 2023 Sep 22;13(1):15792. doi: 10.1038/s41598-023-43141-7.

本文引用的文献

1
Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis.端粒酶的祖先突变导致重复添加持续性缺陷,并表现为家族性肺纤维化。
PLoS Genet. 2011 Mar;7(3):e1001352. doi: 10.1371/journal.pgen.1001352. Epub 2011 Mar 31.
2
Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.疾病特异性造血细胞移植:先天性角化不良的非清髓预处理方案。
Bone Marrow Transplant. 2011 Jan;46(1):98-104. doi: 10.1038/bmt.2010.65. Epub 2010 Apr 12.
3
Syndromes of telomere shortening.端粒缩短综合征
Annu Rev Genomics Hum Genet. 2009;10:45-61. doi: 10.1146/annurev-genom-082908-150046.
4
Cancer in dyskeratosis congenita.先天性角化不良中的癌症。
Blood. 2009 Jun 25;113(26):6549-57. doi: 10.1182/blood-2008-12-192880. Epub 2009 Mar 12.
5
Short telomeres are a risk factor for idiopathic pulmonary fibrosis.短端粒是特发性肺纤维化的一个风险因素。
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13051-6. doi: 10.1073/pnas.0804280105. Epub 2008 Aug 27.
6
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.TINF2突变导致端粒极短:对一大群先天性角化不良和相关骨髓衰竭综合征患者的分析。
Blood. 2008 Nov 1;112(9):3594-600. doi: 10.1182/blood-2008-05-153445. Epub 2008 Jul 30.
7
Telomere shortening in familial and sporadic pulmonary fibrosis.家族性和散发性肺纤维化中的端粒缩短
Am J Respir Crit Care Med. 2008 Oct 1;178(7):729-37. doi: 10.1164/rccm.200804-550OC. Epub 2008 Jul 17.
8
TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.TINF2是端粒保护复合体shelterin的一个组成部分,在先天性角化不良中发生突变。
Am J Hum Genet. 2008 Feb;82(2):501-9. doi: 10.1016/j.ajhg.2007.10.004. Epub 2008 Jan 31.
9
Dyskeratosis congenita: a genetic disorder of many faces.先天性角化不良:一种具有多种表现的遗传性疾病。
Clin Genet. 2008 Feb;73(2):103-12. doi: 10.1111/j.1399-0004.2007.00923.x. Epub 2007 Nov 14.
10
Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.先天性角化不良:端粒酶缺陷认识及干细胞移植作用的进展
Pediatr Transplant. 2007 Sep;11(6):584-94. doi: 10.1111/j.1399-3046.2007.00721.x.

骨髓衰竭和肺纤维化综合征预示着端粒酶的种系缺陷。

Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase.

机构信息

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Blood. 2011 May 26;117(21):5607-11. doi: 10.1182/blood-2010-11-322149. Epub 2011 Mar 24.

DOI:10.1182/blood-2010-11-322149
PMID:21436073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3110022/
Abstract

Mutations in the essential telomerase components hTERT and hTR cause dyskeratosis congenita, a bone marrow failure syndrome characterized by mucocutaneous features. Some (~ 3%) sporadic aplastic anemia (AA) and idiopathic pulmonary fibrosis cases also carry mutations in hTERT and hTR. Even though it can affect clinical outcome, because the mutation frequency is rare, genetic testing is not standard. We examined whether the cooccurrence of bone marrow failure and pulmonary fibrosis in the same individual or family enriches for the presence of a telomerase mutation. Ten consecutive individuals with a total of 36 family members who fulfilled these criteria carried a germline mutant telomerase gene (100%). The mean age of onset for individuals with AA was significantly younger than that for those with pulmonary fibrosis (14 vs 51; P < .0001). Families displayed autosomal dominant inheritance and there was an evolving pattern of genetic anticipation, with the older generation primarily affected by pulmonary fibrosis and successive generations by bone marrow failure. The cooccurrence of AA and pulmonary fibrosis in a single patient or family is highly predictive for the presence of a germline telomerase defect. This diagnosis affects the choice of bone marrow transplantation preparative regimen and can prevent morbidity.

摘要

端粒酶成分 hTERT 和 hTR 的突变会导致先天性角化不良,这是一种骨髓衰竭综合征,其特征为黏膜皮肤表现。一些(约 3%)散发性再生障碍性贫血(AA)和特发性肺纤维化病例也存在 hTERT 和 hTR 的突变。尽管它可能影响临床结果,但由于突变频率较低,因此遗传检测不是标准检测。我们研究了同一患者或家族中骨髓衰竭和肺纤维化的同时发生是否会增加端粒酶突变的存在。连续 10 例符合这些标准的个体共有 36 名家庭成员,携带胚系突变端粒酶基因(100%)。AA 患者的发病年龄明显低于肺纤维化患者(14 岁 vs 51 岁;P <.0001)。家族呈现常染色体显性遗传,存在遗传预期的演变模式,即老一辈主要受肺纤维化影响,而后续几代则受骨髓衰竭影响。单个患者或家族中 AA 和肺纤维化的同时发生高度提示存在胚系端粒酶缺陷。这种诊断会影响骨髓移植预处理方案的选择,并可预防发病。